AL-LAD
From Wikipedia, the free encyclopedia
 |
|
|
AL-LAD
|
|
| Systematic (IUPAC) name | |
| 6-allyl-6-nor-lysergic acid diethylamide | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C22H27N3O |
| Mol. mass | 349.469 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
AL-LAD, also known as 6-allyl-6-nor-lysergic acid diethylamide, is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. AL-LAD is a hallucinogenic drug similar to LSD, and is around the same potency as LSD itself with an active dose reported at between 80 and 160 micrograms. AL-LAD has subtly different effects to LSD, and appears to be slightly shorter lasting.
AL-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
AL-LAD, ALD-52, BU-LAD, CYP-LAD, Diallyllysergamide, DAM-57, Ergonovine, ETH-LAD, LAE-32, LSD, LPD-824, LSM-775, Methylergonovine, MLD-41, PARGY-LAD, PRO-LAD
